OBJECTIVES: The study was designed to provide clinical outcome data for two treatments of the shortened dental arch (SDA). MATERIAL AND METHODS: In a multicenter randomized controlled clinical trial, patients with complete molar loss in one jaw were provided with either a partial removable dental prosthesis (PRDP) retained with precision attachments or treated according to the SDA concept preserving or restoring a premolar occlusion. No implants were placed. The primary outcome was tooth loss. RESULTS: Of 152 treated patients, 132 patients reached the 5-year examination. Over 5 years, 38 patients experienced tooth loss. For the primary outcome tooth loss, the Kaplan-Meier survival rates at 5 years were 0.74 (95% CI 0.64, 0.84) in the PRDP group and 0.74 (95% CI 0.63, 0.85) in the SDA group. For tooth loss in the study jaw, the survival rates at 5 years were 0.88 (95% CI 0.80, 0.95) in the PRDP group and 0.84 (95% CI 0.74, 0.93) in the SDA group. The differences were not significant. No Cox regression models of appropriate fit explaining tooth loss on the patient level could be found. CONCLUSIONS: The overall treatment goals of a sustainable oral rehabilitation and the avoidance of further tooth loss over longer periods were not reliably achievable. The influence of the type of prosthetic treatment on tooth loss might have been overestimated. CLINICAL RELEVANCE: Regarding our results, the patient's view will gain even more importance in the clinical decision between removable and fixed restorations in SDAs.
RCT Entities:
OBJECTIVES: The study was designed to provide clinical outcome data for two treatments of the shortened dental arch (SDA). MATERIAL AND METHODS: In a multicenter randomized controlled clinical trial, patients with complete molar loss in one jaw were provided with either a partial removable dental prosthesis (PRDP) retained with precision attachments or treated according to the SDA concept preserving or restoring a premolar occlusion. No implants were placed. The primary outcome was tooth loss. RESULTS: Of 152 treated patients, 132 patients reached the 5-year examination. Over 5 years, 38 patients experienced tooth loss. For the primary outcome tooth loss, the Kaplan-Meier survival rates at 5 years were 0.74 (95% CI 0.64, 0.84) in the PRDP group and 0.74 (95% CI 0.63, 0.85) in the SDA group. For tooth loss in the study jaw, the survival rates at 5 years were 0.88 (95% CI 0.80, 0.95) in the PRDP group and 0.84 (95% CI 0.74, 0.93) in the SDA group. The differences were not significant. No Cox regression models of appropriate fit explaining tooth loss on the patient level could be found. CONCLUSIONS: The overall treatment goals of a sustainable oral rehabilitation and the avoidance of further tooth loss over longer periods were not reliably achievable. The influence of the type of prosthetic treatment on tooth loss might have been overestimated. CLINICAL RELEVANCE: Regarding our results, the patient's view will gain even more importance in the clinical decision between removable and fixed restorations in SDAs.
Authors: Marc Schätzle; Harald Löe; Niklaus P Lang; Walter Bürgin; Age Anerud; Hans Boysen Journal: J Clin Periodontol Date: 2004-12 Impact factor: 8.728
Authors: Lynn B Copeland; Elizabeth A Krall; L Jackson Brown; Raul I Garcia; Charles F Streckfus Journal: J Public Health Dent Date: 2004 Impact factor: 1.821
Authors: Daniel R Reissmann; Guido Heydecke; Oliver Schierz; Birgit Marré; Stefan Wolfart; Joerg R Strub; Helmut Stark; Peter Pospiech; Torsten Mundt; Wolfgang Hannak; Sinsa Hartmann; Bernd Wöstmann; Ralph G Luthardt; Klaus W Böning; Matthias Kern; Michael H Walter Journal: Clin Oral Investig Date: 2014-01-23 Impact factor: 3.573
Authors: Jaana-Sophia Kern; Stefan Wolfart; Ralf-Dieter Hilgers; Birgit Marré; Herbert Scheller; Jörg Strub; Klaus Böning; Wolfgang Hannak; Ralph G Luthardt; Guido Heydecke; Jan Huppertz; Peter Pospiech; Bernd Wöstmann; Helmut Stark; Torsten Mundt; Florentine Jahn; Matthias Kern; Daniel Edelhoff; Michael H Walter Journal: Clin Oral Investig Date: 2016-10-26 Impact factor: 3.573
Authors: S Wolfart; F Müller; J Gerß; G Heyedcke; B Marré; K Böning; B Wöstmann; M Kern; T Mundt; W Hannak; J Brückner; N Passia; F Jahn; S Hartmann; H Stark; E J Richter; W Gernet; R G Luthardt; M H Walter Journal: Clin Oral Investig Date: 2013-05-17 Impact factor: 3.573